Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
NCT00430053 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2012-03-15
Summary
RATIONALE: Gathering information about patients with cutaneous T-cell lymphoma over time may help doctors learn more about the disease.
PURPOSE: This natural history study is collecting disease-related health information over time from patients with cutaneous T-cell lymphoma.
Conditions
Interventions
- GENETIC
-
gene rearrangement analysis
- GENETIC
-
polymerase chain reaction
- GENETIC
-
proteomic profiling
- OTHER
-
flow cytometry
- OTHER
-
immunohistochemistry staining method
- PROCEDURE
-
biopsy
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
National Institutes of Health Clinical Center (CC)
lead NIH
Principal Investigators
-
Mark C. Udey, MD, PhD · NCI - Dermatology Branch
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-01-31
- Completion
- 2010-06-30
Countries
- United States
Study Locations
More Related Trials
-
Effect of Denileukin Diftitox on Immune System in CTCL Patients
NCT00254332 ·Status: COMPLETED
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
Study of Anti-telomerase T CD4 Immunity in Melanoma
NCT02838433 ·Status: UNKNOWN ·Phase: NA
-
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
NCT00177268 ·Status: RECRUITING
-
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
NCT04815356 ·Status: RECRUITING ·Phase: PHASE1
-
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
NCT00001158 ·Status: COMPLETED
-
CX3CR1+T Cell Predict Immunotherapy Efficacy
NCT06054152 ·Status: COMPLETED
-
Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors
NCT03114566 ·Status: TERMINATED
-
Identification and Evaluation of Circulating Tumor Cells and Tumor Related Rare Cells in Immunotherapy
NCT03434912 ·Status: UNKNOWN
-
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
NCT00867269 ·Status: RECRUITING
-
Tumor-specific T Cells in Lung Cancer
NCT02515760 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Idiopathic CD4 Lymphocytopenia
NCT02113930 ·Status: COMPLETED
-
Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors
NCT03989050 ·Status: WITHDRAWN
-
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
NCT05230186 ·Status: UNKNOWN
-
Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy
NCT06089967 ·Status: COMPLETED
-
Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology: Potential Biomarker for Emerging Immunotherapies
NCT02880046 ·Status: UNKNOWN
-
Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus
NCT00001985 ·Status: COMPLETED
-
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
NCT03035331 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dendritic Cell Based Therapy of Malignant Melanoma
NCT00197912 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients
NCT00940004 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma
NCT01239875 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Melanoma Patients Immunized with Natural DenDritic Cells
NCT02993315 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Follow-up Study of TScan TCR-T Products
NCT06976736 ·Status: RECRUITING
-
Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma
NCT01875653 ·Status: TERMINATED ·Phase: PHASE3
-
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
NCT05292859 ·Status: COMPLETED